ioversol has been researched along with Coronary Disease in 6 studies
Coronary Disease: An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels.
| Excerpt | Relevance | Reference |
|---|---|---|
| " The study results suggest that ioversol is considered to be the efficacious and safe contrast medium for the cardiovascular angiography." | 2.67 | [Preliminary study and clinical evaluation method of ioversol in angiocardiography--establishment of safety evaluation parameters and reliability of radiographic quality evaluation]. ( Harada, J; Himi, K; Ide, M; Kuribayashi, S; Matsuyama, S; Morimoto, S; Shigeta, A; Takemoto, A; Umemura, J; Yamada, T, 1990) |
| "A 53-year-old man developed transient cortical blindness after coronary angiography, which appears to be an adverse reaction to contrast agent." | 1.31 | Cortical blindness following coronary angiography. ( Kwok, BW; Lim, TT, 2000) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (16.67) | 18.7374 |
| 1990's | 2 (33.33) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rudnick, MR | 1 |
| Davidson, C | 1 |
| Laskey, W | 1 |
| Stafford, JL | 1 |
| Sherwin, PF | 1 |
| Hernández, F | 1 |
| Mora, L | 1 |
| García-Tejada, J | 1 |
| Velázquez, M | 1 |
| Gómez-Blázquez, I | 1 |
| Bastante, T | 1 |
| Albarrán, A | 1 |
| Andreu, J | 1 |
| Tascón, J | 1 |
| Sakamoto, I | 1 |
| Uchida, T | 1 |
| Hayashi, K | 1 |
| Kwok, BW | 1 |
| Lim, TT | 1 |
| Matsuyama, S | 1 |
| Kuribayashi, S | 1 |
| Ide, M | 1 |
| Shigeta, A | 1 |
| Umemura, J | 1 |
| Harada, J | 1 |
| Yamada, T | 1 |
| Himi, K | 1 |
| Takemoto, A | 1 |
| Morimoto, S | 1 |
| Hirshfeld, JW | 1 |
| Wieland, J | 1 |
| Davis, CA | 1 |
| Giles, BD | 1 |
| Passione, D | 1 |
| Ray, MB | 1 |
| Ripley, NS | 1 |
3 trials available for ioversol and Coronary Disease
| Article | Year |
|---|---|
Nephrotoxicity of iodixanol versus ioversol in patients with chronic kidney disease: the Visipaque Angiography/Interventions with Laboratory Outcomes in Renal Insufficiency (VALOR) Trial.
Topics: Aged; Aged, 80 and over; Contrast Media; Coronary Angiography; Coronary Disease; Creatinine; Diabeti | 2008 |
[Preliminary study and clinical evaluation method of ioversol in angiocardiography--establishment of safety evaluation parameters and reliability of radiographic quality evaluation].
Topics: Adolescent; Adult; Aged; Angiocardiography; Clinical Trials as Topic; Contrast Media; Coronary Disea | 1990 |
Hemodynamic and electrocardiographic effects of ioversol during cardiac angiography. Comparison with iopamidol and diatrizoate.
Topics: Blood Pressure; Clinical Trials as Topic; Coronary Angiography; Coronary Disease; Diatrizoate; Doubl | 1989 |
3 other studies available for ioversol and Coronary Disease
| Article | Year |
|---|---|
Comparison of iodixanol and ioversol for the prevention of contrast-induced nephropathy in diabetic patients after coronary angiography or angioplasty.
Topics: Aged; Angioplasty, Balloon, Coronary; Contrast Media; Coronary Angiography; Coronary Disease; Creati | 2009 |
Case report: cardiac arrest due to coronary artery spasm during angiographic procedure.
Topics: Aged; Contrast Media; Coronary Angiography; Coronary Disease; Heart Arrest; Humans; Male; Spasm; Tri | 1997 |
Cortical blindness following coronary angiography.
Topics: Acute Disease; Blindness, Cortical; Contrast Media; Coronary Angiography; Coronary Disease; Follow-U | 2000 |